Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25412467 | 0.86 | TSHR (0.47) | LMNAL3MBTL1KMT2ARAB9AMEN1 | |
| SCHEMBL25412469 | 0.86 | TSHR (0.47) | LMNAL3MBTL1KMT2ARAB9AMEN1 | |
| SCHEMBL29793393 | 0.86 | ESR1 (0.42) | LMNAL3MBTL1ESR1ESR2KMT2A | |
| SCHEMBL29793383 | 0.85 | LMNA (0.43) | LMNAL3MBTL1ESR1ESR2KMT2A | |
| SCHEMBL24686277 | 0.83 | KMT2A (0.56) | LMNAESR1ESR2KMT2AMAOA | |
| SCHEMBL29793354 | 0.83 | KMT2A (0.56) | LMNAESR1ESR2KMT2AMAOA | |
| SCHEMBL31154563 | 0.81 | TNFRSF1A (0.48) | LMNAL3MBTL1KMT2ARAB9AMEN1 | |
| SCHEMBL25410639 | 0.78 | KMT2A (0.48) | LMNAL3MBTL1KMT2AMAOBRAB9A | |
| SCHEMBL25410633 | 0.78 | KMT2A (0.48) | LMNAL3MBTL1KMT2AMAOBRAB9A | |
| SCHEMBL29793366 | 0.78 | KMT2A (0.48) | LMNAL3MBTL1KMT2AMAOBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220235024-A1 | ACYLOXY SUBSTITUTED PHENYL DITHIANE DERIVATIVES | Renovel Innovations, Inc. | 2022-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235024-A1 | ACYLOXY SUBSTITUTED PHENYL DITHIANE DERIVATIVES | AADAC, TBXA2R, DECR2 | LMNA 3110/4885L3MBTL1 3854/4885ESR1 3726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.